Diabetes emergencies around Ramadan study (DEARS)-A multi-center study of diabetes emergencies admitted before, during and after Ramadan in Malaysia

被引:4
|
作者
Tong, Chin Voon [1 ]
Yow, Hui Yin [2 ]
Noor, Nurain Mohd [3 ]
Hussein, Zanariah [3 ]
机构
[1] Malacca Gen Hosp, Dept Med, Jalan Mufti Haji Khalil, Malacca 75400, Malaysia
[2] Taylors Univ, Fac Hlth & Med Sci, Sch Pharm, Subang Jaya, Malaysia
[3] Putrajaya Hosp, Dept Med, Putrajaya, Malaysia
关键词
Diabetes; Fasting; Hypoglycemia; Diabetes ketoacidosis; Hyperosmolar hyperglycemic state;
D O I
10.1016/j.diabres.2021.108854
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The objective of this study was to determine admissions for diabetes emergencies among patients who fasted or planned to fast one month before, during and one month after Ramadan 2019 in public hospitals in Malaysia. Materials and methods: This was a cross sectional prospective study done in 18 public hospitals in Malaysia from 7/4/2019 to 2/7/2019. Data was collected prospectively with universal sampling. All adult Muslim patients with previous diagnosis of diabetes, who were admitted for hypoglycemia, DKA or HHS were included if they had fasted and had intentions to fast. Results: 295 admissions for diabetes emergencies were analyzed. The pre-Ramadan period recorded the highest number of admissions (119) followed by during (106) and post Ramadan (70). Admissions for hyperglycemic emergencies accounted for 2/3 of total admissions. 37% of admissions for hypoglycemia occurred during pre-Ramadan period compared to 32.1% during Ramadan. Contributing factors included use of sulphonylurea (59.6%), presence of nephropathy (54.5%) and past history of hypoglycemia (45.5%). Admissions for DKA were more common than HHS (119 versus 77) and highest during Ramadan period (36.1%). Most of the admissions for hyperglycemic emergencies were among those with Type 2 diabetes (75.9% for DKA and 97.4% for HHS). Only 31.5% of patients admitted for diabetes emergencies recalled having received Ramadan advice in the past. Discussion: Admissions for diabetes emergencies were highest during pre-Ramadan period followed by Ramadan and post-Ramadan period. This suggests that fasting during Ramadan does not increase admissions for diabetes emergencies. (c) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] The Effect of Vildagliptin Relative to Sulphonylureas in Muslim Patients With Type 2 Diabetes Fasting During Ramadan: The VIRTUE Study
    Al Arouj, Monira
    Hassoun, Ahmed A. K.
    Medlej, Rita
    Pathan, Faruque M.
    Shaltout, Inass
    Chawla, Manoj S.
    Geransar, Parnia
    Hristoskova, Sashka
    Ditommaso, Shelley
    Kadwa, Mahomed Y.
    DIABETES, 2013, 62 : A288 - A289
  • [42] A Multi-Center Study of Diabetes Eye Screening in Community Settings in the United States
    Owsley, Cynthia
    Friedman, David
    Haller, Julia
    Lee, David
    Saaddine, Jinan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [43] Glycemic fluctuations, fatigue, and sleep disturbances in type 2 diabetes during ramadan fasting: A cross-sectional study
    Pratama, Satwika Arya
    Kurniawan, Rudy
    Chiu, Hsiao-Yean
    Kuo, Hsuan-Ju
    Ekpor, Emmanuel
    Kung, Po-Jen
    Al Baqi, Safiruddin
    Hasan, Faizul
    Romadlon, Debby Syahru
    PLOS ONE, 2025, 20 (03):
  • [44] New Onset Diabetes after Transplant (NODAT) in Hispanic Kidney Transplant Recipients: A Multi-Center Retrospective Study
    Alsheikh, R.
    Kodali, L.
    Alfayez, O.
    Alshibani, M.
    Basilim, A.
    Fazel, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1008 - 1009
  • [45] Patterns of Diabetes Care Among People with Type 1 Diabetes During Ramadan: An International Prospective Study (DAR-MENA T1DM)
    Al Awadi, Fatheya F.
    Echtay, Akram
    Al Arouj, Monira
    Ali, Sobia Sabir
    Shehadeh, Naim
    Al Shaikh, Abdulrahman
    Djaballah, Khier
    Dessapt-Baradez, Cecile
    Abu-Hijleh, Mohamad Omar
    Bennakhi, Abdullah
    Gharbi, Mohamed El Hassan
    El Hadidy, Khaled El Sayed
    Khazaal, Faris Abdul Kareem
    Hassanein, Mohamed M.
    ADVANCES IN THERAPY, 2020, 37 (04) : 1550 - 1563
  • [46] Evaluation of the effectiveness and tolerability of gliclazide modified release 60 mg in patients with type 2 diabetes observing fasting during Ramadan in Pakistan: An analysis from the global DIA-RAMADAN study
    Raza, Syed Abbas
    Akram, Javed
    Aamir, Azizul Hasan
    Ahmedani, Yakoob
    Hassan, Mohammad Imtiaz
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 181
  • [47] Patterns of Diabetes Care Among People with Type 1 Diabetes During Ramadan: An International Prospective Study (DAR-MENA T1DM)
    Fatheya F. Al Awadi
    Akram Echtay
    Monira Al Arouj
    Sobia Sabir Ali
    Naim Shehadeh
    Abdulrahman Al Shaikh
    Khier Djaballah
    Cecile Dessapt-Baradez
    Mohamad Omar Abu-Hijleh
    Abdullah Bennakhi
    Mohamed El Hassan Gharbi
    Khaled El Sayed El Hadidy
    Faris Abdul Kareem Khazaal
    Mohamed M. Hassanein
    Advances in Therapy, 2020, 37 : 1550 - 1563
  • [48] Diabetes During the Fasting Month of Ramadan: Is Telemedicine as Efficient as Conventional Follow-Up? Results from a Moroccan Comparative Study
    Motaib, Imane
    Elamari, Saloua
    Khalis, Mohamed
    Oudghiri, Meryem Drissi
    Laidi, Soukaina
    Chadli, Asma
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 3959 - 3964
  • [49] Safety and tolerability of Empagliflozin use during the holy month of Ramadan by fasting patients with type 2 diabetes: A prospective cohort study
    Samkari, Mayada M.
    Bokhari, Neda'a S.
    Alhajaji, Raghad
    Ahmed, Malaz E.
    Al Raddadi, Ahmad
    Bahget, Alaa K.
    Saleh, Sarah F.
    Aljehani, Faisal
    Alzahrani, Saud H.
    Alsifyani, Sarah S.
    Samkari, May M.
    Badr, Aisha F.
    Alalawi, Mai
    Al Sulaiman, Khalid
    SAUDI PHARMACEUTICAL JOURNAL, 2023, 31 (06) : 972 - 978
  • [50] Transient increase in glucose variability during Ramadan fasting in patients with insulin-treated type 2 diabetes: A preliminary study
    Elmalti, Akrem
    Mukhtar, Mamoun
    Kenz, Sami
    Skaria, Sijomol
    Elgzyri, Targ
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (04)